Home Medical Devices Blood Glucose Test Strips Market Size & Analysis Report | 2033

Blood Glucose Test Strips Market Size, Share & Trends Analysis Report By Technology (Glucose Dehydrogenase (GDH), Glucose Oxidase (GOD)), By Distribution Channel (Online, Offline), By End-User (Individuals, Hospitals and Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD55110DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Blood Glucose Test Strips Market Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Glucose Dehydrogenase (GDH)
          1. By Value
        3. Glucose Oxidase (GOD)
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Online
          1. By Value
        3. Offline
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Individuals
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Glucose Dehydrogenase (GDH)
          1. By Value
        3. Glucose Oxidase (GOD)
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Online
          1. By Value
        3. Offline
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Individuals
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Glucose Dehydrogenase (GDH)
          1. By Value
        3. Glucose Oxidase (GOD)
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Online
          1. By Value
        3. Offline
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Individuals
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Glucose Dehydrogenase (GDH)
          1. By Value
        3. Glucose Oxidase (GOD)
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Online
          1. By Value
        3. Offline
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Individuals
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Glucose Dehydrogenase (GDH)
        1. By Value
      3. Glucose Oxidase (GOD)
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Online
        1. By Value
      3. Offline
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Individuals
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Glucose Dehydrogenase (GDH)
          1. By Value
        3. Glucose Oxidase (GOD)
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Online
          1. By Value
        3. Offline
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Individuals
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Blood Glucose Test Strips Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. F. Hoffmann-La Roche’s Diabetes Care
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. LifeScan
    3. Abbott’s Diabetes Care Division
    4. Ascensia Diabetes Care
    5. Elektronika Kft
    6. AgaMatrix
    7. Alliance International
    8. B. Braun Melsungen
    9. Easymax
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global blood glucose lancets market size was valued at USD 1.58 billion in 2023. It is estimated to reach USD 3.60 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2024–2032). The global blood glucose lancets market is
Buy Now
Global Report
Blood Glucose Test Strip Packaging Market Size The global blood glucose test strip packaging market size was valued at USD 2405.65 million in 2024 and is projected to reach from USD 2566.83 million in 2025 to USD 4312.3
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :